K2M Group Holdings Inc (KTWO) Shares Bought by Broadview Advisors LLC

Broadview Advisors LLC boosted its position in K2M Group Holdings Inc (NASDAQ:KTWO) by 1.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 504,915 shares of the medical device company’s stock after buying an additional 6,950 shares during the quarter. K2M Group makes up about 2.4% of Broadview Advisors LLC’s holdings, making the stock its 6th biggest position. Broadview Advisors LLC’s holdings in K2M Group were worth $13,820,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. DekaBank Deutsche Girozentrale acquired a new position in K2M Group in the 3rd quarter valued at $115,000. Nuance Investments LLC acquired a new position in K2M Group in the 3rd quarter valued at $33,570,000. FIL Ltd acquired a new position in K2M Group in the 3rd quarter valued at $47,473,000. BlackRock Inc. grew its stake in K2M Group by 3.8% in the 3rd quarter. BlackRock Inc. now owns 3,160,991 shares of the medical device company’s stock valued at $86,516,000 after buying an additional 116,360 shares during the last quarter. Finally, Alliancebernstein L.P. grew its stake in K2M Group by 111.8% in the 3rd quarter. Alliancebernstein L.P. now owns 110,517 shares of the medical device company’s stock valued at $3,025,000 after buying an additional 58,327 shares during the last quarter.

KTWO has been the topic of a number of research analyst reports. Oppenheimer set a $25.00 target price on shares of K2M Group and gave the company a “buy” rating in a research note on Thursday, August 2nd. Needham & Company LLC raised their target price on shares of K2M Group from $23.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, August 2nd. BidaskClub lowered shares of K2M Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, July 27th. ValuEngine raised shares of K2M Group from a “hold” rating to a “buy” rating in a report on Thursday, August 30th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $28.00 price target on shares of K2M Group in a report on Thursday, August 30th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $26.17.

In other K2M Group news, CFO Gregory S. Cole sold 82,304 shares of the stock in a transaction on Thursday, August 30th. The shares were sold at an average price of $27.40, for a total value of $2,255,129.60. Following the completion of the sale, the chief financial officer now directly owns 147,963 shares of the company’s stock, valued at approximately $4,054,186.20. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 6.00% of the stock is owned by corporate insiders.

Shares of K2M Group stock opened at $27.50 on Friday. The company has a quick ratio of 1.79, a current ratio of 3.10 and a debt-to-equity ratio of 0.55. K2M Group Holdings Inc has a fifty-two week low of $16.44 and a fifty-two week high of $27.50. The firm has a market capitalization of $1.20 billion, a price-to-earnings ratio of -31.61 and a beta of 1.43.

K2M Group (NASDAQ:KTWO) last issued its quarterly earnings results on Thursday, November 8th. The medical device company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.12). K2M Group had a negative net margin of 16.66% and a negative return on equity of 19.69%. On average, equities research analysts expect that K2M Group Holdings Inc will post -0.77 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by WKRB News and is the sole property of of WKRB News. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://www.wkrb13.com/2018/11/23/k2m-group-holdings-inc-ktwo-shares-bought-by-broadview-advisors-llc.html.

K2M Group Profile

K2M Group Holdings, Inc, a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor.

Featured Article: How does a reverse stock split work?

Want to see what other hedge funds are holding KTWO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for K2M Group Holdings Inc (NASDAQ:KTWO).

Institutional Ownership by Quarter for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply